BioTrinity 2007 featured five key deals including alliance and financing rounds of $50m and up
| Wednesday 28 March 2007 | |
| 09:35- | Key Deals |
| Selected Key Deals from Leading Growth Companies including licensing deals or acquisitions of $300m and up. Chaired by Mike Ward, Senior Editor (Europe), BioCentury | |
| 09:35-09:55 |
Dr Alex Chanas - Pfizer Ltd, Licensing Director "The role of the PowderMed acquisition in Pfizer Vaccines strategic development"
|
| 09:55-10:15 |
Dr Anker Lundemose - Executive VP, President (OSI) Prosidion, OSI Pharmaceuticals, Inc. President, Prosidion Limited
"Licensing of the Glucokinase Program for Diabetes to Eli Lilly"
|
| 10:15-10:30 |
Tony Longstaff, MD, MEPC Milton Park
"Reaching critical mass in Oxfordshire: Milton Park Bioscience Campus"
|
| 10:30-11:00 |
Coffee/tea break, Networking and Exhibits (Sponsored by SEHTA)
|
Confirmed speakers please register as soon as possible
Submit your email address to receive conference updates
PROJECT PARTNERS
|
|
|
|
|
 |
|
|
|
